Advertisement

Topics

Citing rising legal expenses and falling sales of #opioid-based key product, Insys ($INSY) warns of Chapter 11 #bankruptcy filing: http://ow.ly/CniJ50u9Ih8 

17:55 EDT 13 May 2019 | Genetic Engineering News

Citing rising legal expenses and falling sales of -based key product, Insys ($INSY) warns of Chapter 11 filing: http://ow.ly/CniJ50u9Ih8 

Original Article: Citing rising legal expenses and falling sales of #opioid-based key product, Insys ($INSY) warns of Chapter 11 #bankruptcy filing: http://ow.ly/CniJ50u9Ih8 

NEXT ARTICLE

More From BioPortfolio on "Citing rising legal expenses and falling sales of #opioid-based key product, Insys ($INSY) warns of Chapter 11 #bankruptcy filing: http://ow.ly/CniJ50u9Ih8 "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...